Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study
Phase of Trial: Phase III
Latest Information Update: 14 Apr 2016
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypertriglyceridaemia; Low HDL cholesterol
- Focus Pharmacodynamics
- Acronyms EZEmRNA
- 31 Aug 2018 Biomarkers information updated
- 11 Apr 2016 Status changed from recruiting to completed.
- 31 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015, as reported by ClinicalTrials.gov.